Eli Lilly unit opens research facility, inks MOU to work on trials


LILLY Centre for Clinical Pharmacology (LCCP), a subsidiary of US-based Eli Lilly and Company, has opened a 40,600 square foot, S$30 million research facility in Biopolis.

LCCP conducts clinical trials in healthy participants and patients, with a primary focus on first human dose studies and the development of new medicines for diabetes.

The new research facility includes nurse stations, wards, a pharmacy, a laboratory and a recreation room.

"Singapore is recognised as a regional centre of...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to